Cargando…
Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
BACKGROUND: Carcinoma of the breast is the second leading cause of malignant pleural effusions. This study reports on the efficacy of mitoxantrone as a sclerosing agent in patients with breast cancer who had a pleural effusion as a direct consequence of metastatic disease. PATIENTS AND METHODS: Over...
Autores principales: | Barbetakis, Nikolaos, Antoniadis, Theodoros, Tsilikas, Christodoulos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420258/ https://www.ncbi.nlm.nih.gov/pubmed/15153245 http://dx.doi.org/10.1186/1477-7819-2-16 |
Ejemplares similares
-
Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004) -
Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases
por: Barbetakis, Nikolaos, et al.
Publicado: (2010) -
Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
por: Ibrahim, Islam M, et al.
Publicado: (2015) -
Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin
por: Rafiei, Rahmatollah, et al.
Publicado: (2014) -
Cardiac Tamponade Secondary to Metastasis from Adenocarcinoma of the Parotid Gland
por: Barbetakis, Nikolaos G, et al.
Publicado: (2003)